Ventyx Biosciences Inc (VTYX) concluded trading on 12/21/23 at a closing price of $2.22, with 2.18 million shares of worth about $4.85 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -93.23% during that period and on Thursday the price saw a gain of about 6.73%. Currently the company’s common shares owned by public are about 56.98M shares, out of which, 44.55M shares are available for trading.
According to filings with the U.S. Securities and Exchange Commission (SEC), insiders took part in trade of the company’s stock for 183 times over the past 12 months. They bought 634,766 shares in 37 of the transactions. In 146 selling transactions, insiders dumped 11,935,661 shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Ventyx Biosciences Inc (NASDAQ: VTYX) started trading at $2.12, above $0.04 from concluding price of the previous day. However, the stock later moved at a day high price of 2.2500, or with a gain of 6.73%. Stock saw a price change of -4.72% in past 5 days and over the past one month there was a price change of -4.72%. Year-to-date (YTD), VTYX shares are showing a performance of -93.23% which decreased to -92.97% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $2.06 but also hit the highest price of $47.25 during that period. The average intraday trading volume for Ventyx Biosciences Inc shares is 2.57 million. The stock is currently trading -0.40% below its 20-day simple moving average (SMA20), while that difference is down -70.95% for SMA50 and it goes to -92.03% lower than SMA200.
Ventyx Biosciences Inc (NASDAQ: VTYX) currently have 56.98M outstanding shares and institutions hold larger chunk of about 74.11% of that.
The stock has a current market capitalization of $130.91M and its 3Y-monthly beta is at -1.14. It has posted earnings per share of -$3.12 in the same period. It has Quick Ratio of 11.76 while making debt-to-equity ratio of 0.04. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for VTYX, volatility over the week remained 6.52% while standing at 6.52% over the month.
Analysts are in expectations that Ventyx Biosciences Inc (VTYX) stock would likely to be making an EPS of -$0.9 in the current quarter, while forecast for next quarter EPS is -$0.87 and it is -$2.87 for next year. For the current quarter EPS, analysts have given the company a lowest target -$1.24 which is -$0.62 at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of -$0.62 in the same quarter a year ago. Stock’s fiscal year EPS is expected to drop by -62.27% while it is estimated to increase by 11.94% in next year.
Analysts at 10 brokerage firms have issued recommendations for the Ventyx Biosciences Inc (VTYX)’s stock and average of those rates the stock at a “Moderate Buy” and assign it a score of 2.40. Out of those 10 Wall Street analysts, 3 recommended a “Buy” rating, while 7 were in favor recommending the stock as a “Hold” and 0 analyst recommended the stock as “Sell”.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Wells Fargo on November 07, 2023 offering an Equal weight rating for the stock and assigned a target price range of between $77 and $8 to it.
